Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05513040

Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Functional dyspepsia (FD) is one of most common chronic gastrointestinal disorders. Several types of drugs were demonstrated to be effective in reduction or remission of symptoms and severity of FD, including proton pump inhibitors (PPI), Tricyclic antidepressant and prokinetics. However, the clinical course of FD after taking medication-based treatment was unknown. Furthermore, 20-50% patients remained persistent or worsening of dyspepsia symptoms after treatment. Previous studies have suggested psychological factors (eg. anxiety, sleep disturbance) were related to less improvement of symptoms in natural clinical course. However, there is limited evidence in terms of clinical and psychological factors for less improvement in patients receiving medication treatment for dyspepsia.

Conditions

Timeline

Start date
2022-06-01
Primary completion
2025-03-31
Completion
2025-06-01
First posted
2022-08-23
Last updated
2025-04-16

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05513040. Inclusion in this directory is not an endorsement.